Swiss federal institute of technology lausanne, Public university in Zürich, Switzerland

The board of directors at Morepen Laboratories Ltd on Wednesday approved the investment proposed by Corinth Group, a global private investment firm headquartered in Switzerland, to the extent of 100 million dollars (about Rs 750 crore).The funds will be used in scaling up of Morepen's R&D facilities to meet significantly enhanced active pharmaceutical ingredient (API) demand with a market size of 40 billion dollars that Morepen has in the pipeline for the next three years.The company will set up a new US FDA standard API plant to meet the significant ramp up in scale and pipeline.Morepen will also establish a world-class facility for finished dosages as per US FDA standards at its pharma complex in Baddi, Himachal Pradesh, to cater to highly sophisticated and regulated markets like the United States and Japan.Besides, the funds will be used to set up diagnostics facilities including the manufacture of critical inputs/components/enzymes to meet regulated market standards, Morepen said in a statement."India is seeing an exponential jump in household spend on point of care, home diagnostics, oxygen concentrators and other life-support systems with demand currently outstripping supply," it said.Following shareholder and regulatory approval, Corinth will be allotted 58.5 million new equity shares on preferential basis. This shareholding will equate to 9.41 per cent equity stake in the company on a fully expanded capital base. The balance 67.5 million dollars will be in the promoter group compes.The board of directors has also approved allotment of 50 million fresh equity Shares to the promoter group at a price determined by the Securities and Exchange Board of India (SEBI) pricing formula for preferential issuances in lieu of the 98.5 million unsubscribed warrants issued in the last financial year which lapsed due to technical reasons.While the new allotment will be at Rs 38 per share which will be 52 per cent higher than the earlier price of Rs 25 per for each warrant. After subscription of all the warrants, the promoter's stake in the company will go up to 44.28 per cent from 34.54 per cent on a fully diluted basis.Morepen is engaged in the manufacturing and sale of APIs, bulk drugs, home diagnostics, formulations and over-the-counter products.The company's manufacturing facility at Baddi in Himachal Pradesh comprises a scientifically integrated complex of 10 plants, each with a specific product profile.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Swiss Federal Institute Of Technology LausanneFOLLOW

Swiss federal institute of technology lausanne, Latest News

A collaboration agreement centring on refereeing was signed this week between the Mexican Football Association (FMF), the Ecuadorian Football Association (FEF) and FIFA. The initiative is aimed at fostering the exchange of technical knowledge between ...

The White House on Tuesday announced that US President Joe Biden will meet his Russian counterpart Vladimir Putin in Geneva, Switzerland on June 16. ...

Farhad Forbes, Co-chairman, Forbes Marshall, has been re-elected global Chair of Family Business Network International (FBN). ...

Morepen Laboratories said on Friday it has approved an incoming investment of Rs 433 crore to Corinth Investment Holdings AG of Switzerland. ...

Financial and digital solutions major Alankit on Wednesday announced partnership with Digital Swiss Gold (DSG) platform allowing investors to buy and hold physical gold digitally in Switzerland as well as sell and send gold via a mobile app. ...

Founder of 'Mindblowing' productions, Aman Prajapati garnered more than 29 million views on YouTube on his latest Punjabi hit, 'Miss You Enna Sara 2'. ...

Switzerland through the Swiss humanitarian aid will send medical supplies to help India tackle COVID-19 crisis. ...

The board of directors at Morepen Laboratories Ltd on Wednesday approved the investment proposed by Corinth Group, a global private investment firm headquartered in Switzerland, to the extent of 100 million dollars (about Rs 750 crore). ...